Smooth muscle myosin inhibition: a novel therapeutic approach for pulmonary hypertension.

PloS One
David HoYou-Tang Shen

Abstract

Pulmonary hypertension remains a major clinical problem despite current therapies. In this study, we examine for the first time a novel pharmacological target, smooth muscle myosin, and determine if the smooth muscle myosin inhibitor, CK-2019165 (CK-165) ameliorates pulmonary hypertension. Six domestic female pigs were surgically instrumented to measure pulmonary blood flow and systemic and pulmonary vascular dynamics. Pulmonary hypertension was induced by hypoxia, or infusion of the thromboxane analog (U-46619, 0.1 µg/kg/min, i.v.). In rats, chronic pulmonary hypertension was induced by monocrotaline. CK-165 (4 mg/kg, i.v.) reduced pulmonary vascular resistance by 22±3 and 28±6% from baseline in hypoxia and thromboxane pig models, respectively (p<0.01 and 0.01), while mean arterial pressure also fell and heart rate rose slightly. When CK-165 was delivered via inhalation in the hypoxia model, pulmonary vascular resistance fell by 17±6% (p<0.05) while mean arterial pressure and heart rate were unchanged. In the monocrotaline model of chronic pulmonary hypertension, inhaled CK-165 resulted in a similar (18.0±3.8%) reduction in right ventricular systolic pressure as compared with sildenafil (20.3±4.5%). Inhibition of smooth muscle...Continue Reading

References

Feb 11, 1993·The New England Journal of Medicine·R RossaintW M Zapol
Jul 15, 1993·The New England Journal of Medicine·M MonchiA T Dinh-Xuan
Feb 18, 1999·Pediatric Research·X Q Yu, O D Saugstad
Jun 15, 2000·Nature Cell Biology·I MoranoM Bader
Jul 9, 2009·Journal of the American College of Cardiology·David B BadeschAdam Torbicki
Jun 22, 2010·The European Respiratory Journal·M HumbertUNKNOWN French Pulmonary Arterial Hypertension Network
Feb 26, 2011·Journal of the American College of Cardiology·Mardi Gomberg-MaitlandRaymond L Benza
Jul 26, 2011·The Journal of Pharmacology and Experimental Therapeutics·Xin ZhaoStephen F Vatner

❮ Previous
Next ❯

Citations

Dec 27, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Jianling LiuLing Yang
Jan 1, 2012·ISRN Obesity·Carmine FinelliNicolina La Sala
Nov 13, 2019·Pharmaceutical Patent Analyst·Hermann Am Mucke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.